Maribao, Kim Estila L.

HRN: 25-79-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/24/2025
12/31/2025
IV
750mg
Q6h
Hemolytic Anemia
Checking Initial Appropriateness 
01/01/2026
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/01/2026
01/08/2026
ORAL
5ml
BID
Pneumonia
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: